CONDITIONS WE SUPPORT
Mycotoxin illness and environmental toxin exposure trigger a cascade of immune, neurological, and metabolic disruptions. SynergyO3 investigates the root biological mechanisms — oxidative stress, immune dysregulation, and impaired detoxification — to design a physician-supervised recovery protocol. Mold toxicity support with physician-supervised EBOO ozone therapy for Encinitas, San Diego, and North County.
Quick Answer
Mold and environmental toxin illness is a mycotoxin-driven immune, neurological, and metabolic disorder. SynergyO3 addresses it through a physician-designed protocol built around EBOO ozone therapy and HOCATT™ sauna support. Your individualized protocol — including session count and duration — is discussed and designed at your appointment with Dr. Heather Volpp, MD. SynergyO3 does not order labs for mold or environmental toxin evaluation, but if you have relevant lab work already ordered by your own healthcare team, you're welcome to bring it in for her review — this isn't required.
CLINICAL PRESENTATION
Mold and environmental toxin illness presents across multiple body systems simultaneously. Symptoms are often dismissed or misdiagnosed. Individual results vary — Dr. Heather Volpp evaluates each patient's complete clinical picture.
Symptoms often emerge weeks to months after sustained exposure to water-damaged buildings, mycotoxins, or environmental chemicals. Many patients cycle through multiple diagnoses before the toxic exposure link is identified.
Lab findings may include elevated C4a, TGF-β1, and MMP-9 (Shoemaker panel), reduced MSH (melanocyte-stimulating hormone), abnormal ADH/osmolality, elevated mycotoxin levels on urine testing, and disrupted HPA axis markers.
COMMONLY OVERLAPPING CONDITIONS
CLINICAL EDUCATION
Mycotoxins produced by mold species such as Stachybotrys, Aspergillus, and Penicillium are potent biotoxins that impair mitochondrial function, trigger chronic immune activation, and disrupt the HPA axis. Individual biological susceptibility is influenced by HLA-DR gene variants that affect biotoxin clearance.
Approximately 24% of the population carries HLA-DR variants that impair biotoxin clearance. These individuals cannot effectively eliminate mycotoxins through normal pathways, leading to biotoxin recirculation and sustained systemic inflammation.
Mycotoxins cross the blood-brain barrier and activate microglial cells, releasing matrix metalloproteinase-9 (MMP-9). Elevated MMP-9 damages the blood-brain barrier further, perpetuating neurological symptoms including brain fog, anxiety, and cognitive impairment.
Chronic biotoxin exposure suppresses melanocyte-stimulating hormone (MSH), a master regulatory peptide controlling inflammation, sleep architecture, and mucosal immunity. Low MSH perpetuates the inflammatory cascade and increases susceptibility to opportunistic infections.
KEY STATISTICS
Comprehensive intake and clinical assessment to map biological drivers.
Physician-designed sequenced protocol combining EBOO and HOCATT™ therapy.
Functional benchmarks and protocol refinement based on your response.
ROOT CAUSE INVESTIGATION
Dr. Heather Volpp evaluates each patient's complete picture — identifying which biological mechanisms are most active — before any protocol is designed. Individual results vary.
HLA-DR gene variants prevent normal mycotoxin elimination. Biotoxins recirculate through the enterohepatic pathway, maintaining a continuous inflammatory signal that drives symptoms.
Mycotoxins directly inhibit mitochondrial respiration, reduce glutathione reserves, and generate reactive oxygen species — depleting cellular energy production and driving systemic fatigue and pain.
Chronic biotoxin exposure shifts immune balance toward a Th2-dominant state, elevating pro-inflammatory cytokines including TGF-β1, C4a, and TNF-α while suppressing regulatory T-cell function.
SUPPORT APPROACH
All protocols are physician-designed and supervised by Dr. Heather Volpp, MD. Therapies are selected based on each patient's evaluation. Results may vary.
EBOO ozone therapy may support biotoxin clearance by upregulating antioxidant enzyme systems (superoxide dismutase, catalase, glutathione peroxidase), reducing oxidative burden, and supporting mitochondrial function impaired by mycotoxin exposure.
The HOCATT™ combines ozone steam, carbonic acid, far-infrared, and full-spectrum light. May support lymphatic drainage of biotoxins, stimulate heat shock proteins, and activate the autonomic nervous system.
YOUR PATH FORWARD
Booking is direct. Before any EBOO session, Dr. Heather Volpp reviews your complete clinical picture, and no protocol begins until that review is complete. An optional consultation is also available if you would like to discuss your case first.
A comprehensive intake with Dr. Heather Volpp reviewing your symptom timeline, prior lab work, medications, and functional status. SynergyO3 doesn't order labs — if your own healthcare team has ordered relevant labs, you're welcome to bring them in for Dr. Volpp to review as part of the bigger clinical picture.
Based on your evaluation findings, Dr. Heather Volpp designs a sequenced treatment protocol — typically combining EBOO sessions and HOCATT™ therapy at clinically appropriate intervals.
Functional benchmarks and symptom tracking guide protocol adjustments. Follow-up labs assess inflammatory markers and key biomarkers. Treatment frequency is adjusted as you progress toward your goals.
COMMON QUESTIONS
TAKE THE NEXT STEP
You can book directly. No consultation is required. Before any EBOO session, Dr. Heather Volpp, MD, Board-Certified Internal Medicine, reviews your health history and symptoms. If you would like to talk things through first, an optional consultation is available for $150, credited toward your first EBOO session once you book. Consultations typically last 15 to 30 minutes, in person or by phone.
Request Appointment →Physician-Supervised · SynergyO3 Medical · Encinitas, CA · (760) 450-4602
Individual results vary. Consult with Dr. Heather Volpp during your evaluation.
